{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T19:45:36Z","timestamp":1784317536011,"version":"3.55.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2007,12,1]],"date-time":"2007-12-01T00:00:00Z","timestamp":1196467200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,12,1]],"date-time":"2007-12-01T00:00:00Z","timestamp":1196467200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajo.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2007,12]]},"DOI":"10.1016\/j.ajo.2007.07.038","type":"journal-article","created":{"date-parts":[[2007,10,5]],"date-time":"2007-10-05T14:21:22Z","timestamp":1191594082000},"page":"864-871","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":90,"title":["Early Bevacizumab Treatment of Central Retinal Vein Occlusion"],"prefix":"10.1016","volume":"144","author":[{"given":"Daniela C.","family":"Ferrara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Koizumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard F.","family":"Spaide","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajo.2007.07.038_bib1","first-page":"371","article-title":"Central retinal vein occlusion: a prospective histopathologic study of 29 eyes in 28 cases","volume":"79","author":"Green","year":"1981","journal-title":"Trans Am Ophthalmol Soc"},{"key":"10.1016\/j.ajo.2007.07.038_bib2","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.preteyeres.2004.12.001","article-title":"Prevalent misconceptions about acute retinal vascular occlusive disorders","volume":"24","author":"Hayreh","year":"2005","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.ajo.2007.07.038_bib3","first-page":"1425","article-title":"The Central Vein Occlusion Study Group M Report","volume":"102","year":"1995","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2007.07.038_bib4","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1097\/01.iae.0000237111.82357.30","article-title":"One-year safety and efficacy of intravitreal triamcinolone acetonide for the management of macular edema secondary to central retinal vein occlusion","volume":"26","author":"Gregori","year":"2006","journal-title":"Retina"},{"key":"10.1016\/j.ajo.2007.07.038_bib5","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1097\/01.iae.0000231543.45699.e1","article-title":"Intravitreal triamcinolone acetonide treatment of macular edema associated with central retinal vein occlusion","volume":"26","author":"Goff","year":"2006","journal-title":"Retina"},{"key":"10.1016\/j.ajo.2007.07.038_bib6","article-title":"Intravitreal triamcinolone acetonide for macular oedema owing to retinal vein occlusion","author":"Patel","year":"2007","journal-title":"Eye"},{"key":"10.1016\/j.ajo.2007.07.038_bib7","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1007\/s00417-006-0348-9","article-title":"Intravitreal triamcinolone for acute central retinal vein occlusion: a randomized clinical trial","volume":"244","author":"Ramezani","year":"2006","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.ajo.2007.07.038_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10633-006-9032-y","article-title":"Intraocular triamcinolone acetonide for macular edema due to CRVO: a multifocal-ERG and OCT study","volume":"114","author":"Moschos","year":"2007","journal-title":"Doc Ophthalmol"},{"key":"10.1016\/j.ajo.2007.07.038_bib9","doi-asserted-by":"crossref","first-page":"336","DOI":"10.3928\/1542-8877-20050701-15","article-title":"Optical coherence tomography findings after an intravitreal injection of bevacizumab (Avastin) for macular edema from central retinal vein occlusion","volume":"36","author":"Rosenfeld","year":"2005","journal-title":"Ophthalmic Surg Lasers Imaging"},{"key":"10.1016\/j.ajo.2007.07.038_bib10","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/00006982-200603000-00005","article-title":"Intravitreal bevacizumab (Avastin) treatment of macular edema in central retinal vein occlusion: a short-term study","volume":"26","author":"Iturralde","year":"2006","journal-title":"Retina"},{"key":"10.1016\/j.ajo.2007.07.038_bib11","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/IAE.0b013e31802eff83","article-title":"Intravitreal bevacizumab (Avastin) for central and hemicentral retinal vein occlusions: IBeVO study","volume":"27","author":"Costa","year":"2007","journal-title":"Retina"},{"key":"10.1016\/j.ajo.2007.07.038_bib12","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S1386-5056(98)00163-4","article-title":"Measurement and classification of retinal vascular tortuosity","volume":"53","author":"Hart","year":"1999","journal-title":"Int J Med Inform"},{"key":"10.1016\/j.ajo.2007.07.038_bib13","first-page":"210","article-title":"Comparative biomechanics","author":"Vogel","year":"2003"},{"key":"10.1016\/j.ajo.2007.07.038_bib14","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1016\/S0161-6420(98)91234-9","article-title":"The role of weight loss and acetazolamide in the treatment of idiopathic intracranial hypertension (pseudotumor cerebri)","volume":"105","author":"Johnson","year":"1998","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2007.07.038_bib15","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1001\/archopht.1997.01100150488006","article-title":"Natural history and clinical management of central retinal vein occlusion","volume":"115","year":"1997","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ajo.2007.07.038_bib16","first-page":"1434","article-title":"The Central Vein Occlusion Study Group N report","volume":"102","year":"1995","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2007.07.038_bib17","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/S0161-6420(96)30689-1","article-title":"The CVOS Group M and N reports","volume":"103","author":"Hayreh","year":"1996","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2007.07.038_bib18","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0002-9394(98)00069-5","article-title":"Formation of retinochoroidal collaterals in central retinal vein occlusion","volume":"126","author":"Takahashi","year":"1998","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2007.07.038_bib19","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1001\/archopht.121.10.1385","article-title":"Chorioretinal anastomosis after radial optic neurotomy for central retinal vein occlusion","volume":"121","author":"Garciia-Arumii","year":"2003","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ajo.2007.07.038_bib20","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1097\/00006982-200406000-00003","article-title":"Retinal choroidal collateral circulation after radial optic neurotomy correlated with the lessening of macular edema","volume":"24","author":"Spaide","year":"2004","journal-title":"Retina"},{"key":"10.1016\/j.ajo.2007.07.038_bib21","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1007\/s00417-002-0525-4","article-title":"Intentional complete interruption of a retinal vein after vitrectomy might improve the rate of successful chorioretinal venous anastomosis formation in central retinal vein occlusion","volume":"240","author":"Koizumi","year":"2002","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.ajo.2007.07.038_bib22","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1016\/S0161-6420(96)30420-X","article-title":"Intravitreous injections of vascular endothelial growth factor produce retinal ischemia and microangiopathy in an adult primate","volume":"103","author":"Tolentino","year":"1996","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2007.07.038_bib23","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S0002-9394(01)01381-2","article-title":"Pathologic features of vascular endothelial growth factor-induced retinopathy in the nonhuman primate","volume":"133","author":"Tolentino","year":"2002","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2007.07.038_bib24","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/S0161-6420(98)93020-2","article-title":"Vascular endothelial growth factor upregulation in human central retinal vein occlusion","volume":"105","author":"Pe\u2019er","year":"1998","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2007.07.038_bib25","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1056\/NEJM199412013312203","article-title":"Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders","volume":"331","author":"Aiello","year":"1994","journal-title":"N Engl J Med"}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939407006940?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939407006940?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T12:55:26Z","timestamp":1757595326000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002939407006940"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,12]]},"references-count":25,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2007,12]]}},"alternative-id":["S0002939407006940"],"URL":"https:\/\/doi.org\/10.1016\/j.ajo.2007.07.038","relation":{},"ISSN":["0002-9394"],"issn-type":[{"value":"0002-9394","type":"print"}],"subject":[],"published":{"date-parts":[[2007,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Early Bevacizumab Treatment of Central Retinal Vein Occlusion","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2007.07.038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}